Know Cancer

or
forgot password

    • cancer clinical trials in nashville, TN

    • A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
    Dermatology Research Associates, Inc.
    Nashville, Tennessee 37203
    Actinic Keratosis
    Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer
    Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
    Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
    MBCCOP - Meharry Medical College - Nashville

    Trial Locations
    MBCCOP - Meharry Medical College - Nashville
    Nashville Breast Center
    Breast Cancer
    An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Vanderbilt University, Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    Leukemia, Myeloid, Acute
    Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Non-small Cell Lung Cancer Metastatic, Small Cell Lung Carcinoma
    A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    Vanderbilt University Medical Center

    Trial Locations
    Vanderbilt University Medical Center
    Mid South Endocrine Associates
    Cushing's Disease
    Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Neuroblastoma in Remission
    Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
    Investigational Site Number 840007
    Nashville, Tennessee 37232
    Neoplasm Malignant
    Autonomic Phenotype Before and After Akt Inhibition
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Diagnosis of Melanoma
    Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer, ER+ Breast Cancer
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Metastatic Breast Cancer
    A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Vanderbilt University Medical Center Vanderbilt 2
    Nashville, Tennessee 37232
    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC) Patients Who Are Resistant or Ineligible/Intolerant to Platinum-based Chemotherapy., Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

    Nashville, Tennessee 37203-1632
    Prostate Cancer, Castration Resistant Prostate Cancer, Pain, Prostatic Neoplasms
    Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    The Role of Prostaglandins in the Progression of Diabetic Retinopathy
    Vanderbilt Eye Institute
    Nashville, Tennessee 37232-8808
    Inflammation
    Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Advanced BRAF-mutant Cancers
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    Vanderbilt University Medical Center Vanderbilt - Thompson Ln
    Nashville, Tennessee 37232
    Breast Cancer
    PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
    Tennessee Oncology

    Trial Locations
    Tennessee Oncology
    Nashville Breast Center
    Hormone Receptor Positive Malignant Neoplasm of Breast
    Phase 1 Safety Study of X-396, an Oral ALK Inhibitor, in Patients With Advanced Solid Tumors
    Vanderbilt University

    Trial Locations
    Vanderbilt University
    Sarah Cannon Research Institute
    Advanced Solid Tumors
    A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin
    Tennessee Oncology
    Nashville, Tennessee 37203
    Solid Tumor, Non-small-cell Lung Cancer, Lung Cancer
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    Squamous Cell Non-small Cell Lung Cancer
    Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Invasive Ductal Carcinoma, Ductal Carcinoma in Situ
    Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Trismus, Head and Neck Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    Sarah Cannon Research Institute, Site #076
    Nashville, Tennessee 37203
    Chronic Myeloid Leukemia
    Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
    Call for Information (Investigational Site 0232)
    Nashville, Tennessee 37203
    Genital Warts, Anal Cancer, Anal Intraepithelial Neoplasia
    Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Acute Myeloid Leukemia
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Relapsed or Refractory Systemic Light Chain Amyloidosis
    Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Henry-Joyce Cancer Center
    Nashville, Tennessee 37232
    Non-Squamous Cell Non-small Cell Lung Cancer
    Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Obstructive Jaundice, Pancreatic Cancer
    A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders, Chronic Myeloid Leukemia
    LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
    Sarah Cannon Research Institute Dept of Oncology
    Nashville, Tennessee 37203
    Non-Small Cell Lung Cancer
    LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
    Sarah Cannon Research Institute Dept of Oncology
    Nashville, Tennessee 37203
    Non-Small Cell Lung Cancer